|City Silence Every Wednesday
Join others for silent meditation sessions Wednesdays from 7:30 to 8 a.m. on the CARE/Crawley Building steps. The sessions, coordinated by the UC Center for Integrative Health and Wellness, are part of the international City Silence initiative.
|FEATURED: AHC News
Read Academic Health Center news in Featured, the weekly e-newsletter from the public relations office.
Sign up to receive it: email@example.com
|More Ways to Connect With Us
CARE/Crawley Building Entrance
Main Entrance to CARE/Crawley Building
Will Be Closed on Wednesday, Aug. 5
The main entrance to the CARE/Crawley Building (adjacent to the Dean's Suite) will be closed for most of the day Wednesday, Aug. 5, in connection with plans to replace the current doors with a revolving door. The closure, for a preliminary inspection, will begin at 5 a.m. and is expected to last until 3 p.m. Signage will be posted directing foot traffic to the dining area entrance farther north (toward Albert Sabin Way).
Work is scheduled to begin this fall on the revolving door, which will rectify issues that developed when wind sometimes forced open the existing doors. It also will help to better maintain temperature in the CARE/Crawley Atrium.
If you have questions, please contact Gary Wilkin, senior staff engineer with the Office of Planning, Design and Construction, by email or by phone at 513-910-6672.
College of Medicine
Outside Activity Reports Due Sept. 4
To comply with federal deadlines, UC College of Medicine and Hoxworth employees must complete an annual report of collateral employment and outside activity no later than Sept. 4, 2015. All employees—faculty and staff—with a full-time equivalency (FTE) of 50 percent or more must complete the report. In addition, all faculty and staff who engage in research at UC are required to complete the outside activity report regardless of their FTE percentage. Use your central login username and password to complete the Outside Activity Report. Questions should be directed to OARquestions@uc.edu.
Thomas Herzog, MD
Herzog Named to Gynecologic Oncology Group Board
Thomas Herzog, MD, professor in the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, and clinical director of the UC Cancer Institute, has been named to the Gynecologic Oncology Group (GOG), Inc. Foundation Board of Directors. The board is made up of 11 voting members.
The Gynecologic Oncology Group is a nonprofit international organization with the goal of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies.
>> More about the GOG
Sean Davidson, PhD
Carl Fichtenbaum, MD
Davidson, Fichtenbaum Honored in Gallery of Awardees
Sean Davidson, PhD, Department of Pathology and Laboratory Medicine, and Carl Fichtenbaum, MD, Department of Internal Medicine, Division of Infectious Diseases, are currently featured in the Gallery of Awardees in the CARE/Crawley Atrium across from the Dean’s Suite. The display was created by the College of Medicine Office of Research to celebrate faculty members who have been awarded external research grants of $100,000 per year or more.
Faculty honored in this display in addition to others inducted into the Gallery of Awardees will be featured in the College of Medicine Research Awards Program from 4:30 to 6:30 p.m. Wednesday, Sept. 9, in the CARE/Crawley Atrium and Kaplan Reception Area. There will be a pre and post reception.
Lisa Larkin, MD
Larkin Appointed Co-Chair of Sexual Health Coalition
Lisa Larkin, MD, associate professor in the Department of Obstetrics and Gynecology and director of the UC Health Women’s Center, has been appointed scientific co-chair of Even the Score, a Washington, D.C.-based women’s sexual health coalition. In a news release, the coalition said she will serve as an expert voice regarding the need for FDA-approved medical treatment options for women who have hypoactive sexual desire disorder (HSDD).
In June, Larkin offered testimony at an FDA Advisory Committee meeting on the new drug application for flibanserin, a non-hormonal tablet proposed for the treatment of HSDD in premenopausal women. The committee voted 18-6 in favor of recommending approval for flibanserin. Additional review will now follow before the drug can be approved and made available for patients.
UPCOMING LECTURES AND SEMINARS
- Combined Neurosurgery and Radiation Oncology Grand Rounds Aug. 5: Ronald Warnick, MD, will present "25 Years of LINAC Radiosurgery: the University of Cincinnati Experience” at 8 a.m. in Stetson 2108.
- Department of Neurology and Rehabilitation Medicine Grand Rounds Aug. 5: Steven Shapiro, MD, Division of Pediatric Neurology Cincinnati Children’s Hospital Medical Center, will present "Kernicterus and Bilitubin-Induced Neurological Disorders (BIND): From Diagnosis to Treatment” at 8 a.m. in the Sabin Auditorium at Cincinnati Children’s.
- Medical Grand Rounds Aug. 5: Charu Thakar, MD, will present "Acute Care Nephrology: A Case Based Approach” at noon in MSB 5051.